Key result
TAK-242 attenuates aortic medial thickening and perivascular fibrosis in CKD mice.
Findings demonstrate that TLR4 inhibition improves vascular health in CKD, suggesting a new therapeutic avenue.
These findings suggest that TLR4-mediated sterile inflammation may contribute to vascular remodeling in CKD and that modulation of TLR4 signaling could be explored as a potential therapeutic strategy to mitigate cardiovascular complications in CKD patients.
No takes yet. Share an insight, caveat, or question.
Shirouzu et al. (2026) studied Chronic kidney disease-associated vascular remodeling (mouse 5/6 nephrectomy model). TAK-242 (Resatorvid) vs. Vehicle (30% DMSO in PBS) was evaluated on Aortic medial thickness and perivascular fibrosis (p=<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: